目的 系统评价神经外科ICU中呼吸机相关性肺炎(VAP)的危险因素。方法 计算机检索建库至2024-06期间CNKI、VIP、万方数据库、PubMed、Embase、The Cochrane library、CBM和Web of Science等中英文数据库中的相关文献,使用RevMan5.4和stata15.0进行Meta分析。结果 纳入文献11篇,包括中文文献9篇,英文文献2篇,纳入研究对象2022例,对16个可能的危险因素进行综合评价。吸烟、昏迷、APACHEⅡ评分、血清白蛋白<30 g/L、抗生素使用时间>3 d、糖皮质激素使用、镇静剂使用、亚低温治疗、机械通气时间≥5 d、ICU住院时间长10项因素是神经外科ICU发生VAP的危险因素(P＜0.05),早期抗生素使用可降低其VAP的发生(P＜0.05)。结论 临床医护人员应密切关注上述危险因素,早期识别并采取有效的防控措施,减少神经外科ICU内VAP的发生。
Abstract
Objective To systematic evaluate the risk factors for ventilator-associated pneumonia (VAP) in neurosurgery ICU. Methods Relevant literatures in CNKI, VIP, Wanfang, PubMed, Embase, The Cochrane library, CBM, Web of Science and other Chinese and English databases were searched by computer until June 2024. Meta-analysis was performed using RevMan5.4 and stata15.0. Results A total of 11 literatures were included, including 9 Chinese ones and 2 English ones, 2022 subjects were included in the study, and 16 possible risk factors were comprehensively evaluated. Smoking, coma, APACHE Ⅱ score, serum albumin <30 g/L, antibiotic use time >3 d, glucocorticoid use, sedative use, hypothermia treatment, mechanical ventilation time≥5 d, and long ICU stay were the risk factors for VAP in neurosurgery ICU (P＜0.05). Early use of antibiotics could reduce the occurrence of VAP (P＜0.05). Conclusions In order to identify and take effective prevention and control measures in the early stage to reduce the occurrence of VAP in neurosurgery ICU, clinical staff should closely monitor the above mentioned risk factors.
关键词
神经外科 /
重症监护 /
呼吸机相关性肺炎 /
危险因素 /
Meta分析
Key words
neurosurgery /
intensive care /
ventilator associated pneumonia /
risk factors /
meta-analysis
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Fernando S M,Tran A,Cheng W,et al.Diagnosis of ventilator-associated pneumonia in critically ill adult patients-a systematic review and meta-analysis[J].Intensive Care Med,2020,46(6):1170-1179.
[2] 王鑫姝,付 艳,王洪波.ICU机械通气患者呼吸机相关性肺炎血清IL-6、IL-8、PSP水平变化及发病危险因素分析[J].实用预防医学,2021,28(2):216-218.
[3] Kalanuria A A,Fellerman D,Nyquist P,et al.Variability in diagnosis and treatment of ventilator-associated pneumonia in neurocritical care patients[J].Neurocrit Care,2015,23(1):44-53.
[4] Sachdeva D, Singh D, Loomba P,et al.Assessment of surgical risk factors in the development of ventilator-associated pneumonia in neurosurgical intensive care unit patients:alarming observations[J].Neurol India,2017,65(4):779-784.
[5] 王延欢.神经外科重症患者呼吸机相关性肺炎危险因素分析及预防方法[J].临床医药文献电子杂志,2017,4(53):10339-10342.
[6] Stang A.Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J].Eur J Epidemiol,2010,25(9):603-605.
[7] 潘海萍,潘敏敏,周 兰,等.呼吸机相关性肺炎的高危因素及护理对策[J].中西医结合护理,2017,3(6):78-80.
[8] 罗 维,廖若夷,彭 露.某医院ICU患者呼吸机相关肺炎影响因素及对策[J].实用预防医学,2024,31(3):346-349.
[9] 周 慧,王红梅,叶 群,等.神经外科ICU病人呼吸机相关性肺炎风险预测模型的构建[J].护理研究,2022,36(23):4174-4180.
[10] 陶立玉,张玉清,高秀莲,等.神经外科术后患者呼吸机相关性肺炎危险因素分析[J].中国微生态学杂志,2021,33(2):188-192.
[11] 覃绍彩,易红英,张园兰.神经外科重症患者呼吸机相关性肺炎危险因素分析及预防措施[J].中国实用医药,2016,11(5):52-53.
[12] 陶化青.神经外科重症监护室呼吸机相关性肺炎危险因素分析及其护理对策[D].石河子:石河子大学,2016.
[13] 史荣芬.神经外科重症监护室呼吸机相关性肺炎危险因素分析及护理研究[J].医药前沿,2019,9(14):238-239.
[14] 赵建凯.神经外科重症监护室老年患者呼吸机相关性肺炎危险因素分析及应对[D].承德:承德医学院,2018.
[15] 张西强,何多奇,云慧斌, 等.重度颅脑损伤患者早发性呼吸机相关性肺炎临床特征及相关因素的分析[J]. 中国急救医学,2018,38(10):879-884.
[16] Teng G,Wang N,Nie X,et al.Analysis of risk factors for early-onset ventilator-associated pneumonia in a neurosurgical intensive care unit[J].BMC Infect Dis,2022,22(1):66.
[17] Esnault P,Nguyen C,Bordes J,et al.Early-onset ventilator-associated pneumonia in patients with severe traumatic brain injury: incidence, risk factors, and consequences in cerebral oxygenation and outcome[J]. Neurocrit Care,2017,27(2):187-198.
[18] 孙毓奇,万大海,杨远达,等.神经外科重症病人肺部感染危险因素及抗生素治疗方案的研究进展[J].中西医结合心脑血管病杂志,2020,18(5):778-780.
[19] 韩明星,宋玲玲,刘金鹏.ICU机械通气病人呼吸机相关性肺炎危险因素的Meta分析[J].齐齐哈尔医学院学报,2024,45(1):69-74.
[20] 张志燕.慢性阻塞性肺疾病急性加重患者合并呼吸机相关性肺炎危险因素分析[D].南昌:南昌大学,2023.
[21] 辛 恺.ICU机械通气患者呼吸机相关性肺炎危险因素及干预措施[J].牡丹江医学院学报,2017,38(5):45-48.
[22] 何清菊,李青文.呼吸机相关肺炎发病机制及危险因素探讨[J].中国冶金工业医学杂志,2006(2):147-148.
[23] Li F,Yuan M Z,Wang L,et al.Characteristics and prognosis of pulmonary infection in patients with neurologic disease and hypoproteinemia[J].Expert Rev Anti Infect Ther,2015,13(4):521-526.
[24] Karbasy S H,Sabertanha A,Bayati M,et al.Study of the effect of added bronchoscopic suction to routine treatment of ventilator associated pneumonia patients in surgical ICU[J].J Pak Med Assoc,2021,71(5):1326-1331.
[25] Martin L I,Diaz E,Valles J.Risks for multidrug-resistant pathogens in the ICU[J].Curr Opin Crit Care,2014,20(5):516-524.
[26] Souza O A C,Cunha T M,Passos L B,et al.Ventilator-associated pneumonia: the influence of bacterial resistance, prescription errors, and de-escalation of antimicrobial therapy on mortality rates[J].Braz J Infect Dis,2016,20(5):437-443.
[27] Kamata K,Watanabe T,Minaga K, et al.Gut microbiome alterations in type 1 autoimmune pancreatitis after induction of remission by prednisolone[J].Clin Exp Immunol,2020,202(3):308-320.
[28] Bernard S A, Macc J B, Buist M.Experience with prolonged induced hypothermia in severe head injury[J]. Crit Care,1999,3(6):167-172.
[29] 孙友桃,傅秀霞.亚低温治疗导致的呼吸系统并发症及护理进展[J].当代护士,2016(12):6-8.
[30] Barbier W M.Hospital-acquired pneumonia and ventilator-associated pneumonia:recent advances in epidemiology and managemen[J].Curr Opin Pulm Med.,2013,3(19):216-228.
PDF(1675 KB)
